|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
|
RGD |
PMID:18931056 |
RGD:5128825 |
NCBI chrNW_004624782:449,217...590,306
Ensembl chrNW_004624782:449,288...591,310
|
|
G |
Ace |
angiotensin I converting enzyme |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:19383228 PMID:19484664 |
RGD:4140913 RGD:4140919 |
NCBI chrNW_004624849:998,262...1,019,305
Ensembl chrNW_004624849:998,277...1,019,521
|
|
G |
Acsl3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:19221603 |
RGD:13831295 |
NCBI chrNW_004624823:2,323,939...2,387,213
Ensembl chrNW_004624823:2,324,345...2,381,420
|
|
G |
Ada |
adenosine deaminase |
susceptibility |
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:16754522 |
RGD:5128848 |
NCBI chrNW_004624790:9,809,550...9,829,199
Ensembl chrNW_004624790:9,809,492...9,829,883
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
no_association susceptibility disease_progression |
ISO |
DNA:SNPs (human) mRNA:increased expression:lung DNA:SNPs:introns,exon:7575G>A, 11188A>T, 12433T>C (human) DNA:SNPs: :multiple (human) mRNA:increased expression:bronchus DNA:polymorphism: :p.M764T (human) |
RGD |
PMID:16893396 PMID:17339047 PMID:17961406 PMID:18778489 PMID:19635592 PMID:19940503 More...
|
RGD:4145359 RGD:4145360 RGD:4145378 RGD:4145379 RGD:4145380 RGD:4145382 |
NCBI chrNW_004624741:4,764,508...4,778,174
Ensembl chrNW_004624741:4,766,306...4,775,501
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
severity |
ISO |
mRNA:increased expression:bronchus mRNA:increased expression:respiratory tract |
RGD |
PMID:17339047 PMID:19373511 PMID:20194813 |
RGD:4145380 RGD:5128872 RGD:5128878 |
NCBI chrNW_004624737:13,459,274...13,474,686
|
|
G |
Adcy2 |
adenylate cyclase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004624751:5,004,186...5,409,891
Ensembl chrNW_004624751:5,004,263...5,413,994
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21059121 |
|
NCBI chrNW_004624783:271,179...323,785
Ensembl chrNW_004624783:279,745...323,772
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
susceptibility |
ISO |
DNA:SNPs: :rs1154404, rs28730619 (human) protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15919956 PMID:17543375 PMID:19395503 PMID:19514054 |
RGD:5128882 RGD:5128890 RGD:5128891 RGD:5128892 |
NCBI chrNW_004625024:32,237...60,983
Ensembl chrNW_004625024:32,348...63,242
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
|
RGD |
PMID:19168697 |
RGD:5686821 |
NCBI chrNW_004624730:69,941,963...69,959,266
Ensembl chrNW_004624730:69,941,001...69,957,012
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
DNA:SNPs: :1405C>T (human) protein:increased expression:bronchus |
RGD |
PMID:17959644 PMID:19019667 PMID:20400685 |
RGD:4145444 RGD:4890386 RGD:5129097 |
NCBI chrNW_004624807:7,674,164...7,705,736
Ensembl chrNW_004624807:7,674,927...7,705,051
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
DNA:SNP (human) mRNA:decreased expression:aorta |
RGD |
PMID:16339780 PMID:17293374 PMID:18310516 PMID:19019667 |
RGD:4890366 RGD:4890380 RGD:4890385 RGD:4890386 |
NCBI chrNW_004624747:9,846,254...9,860,938
Ensembl chrNW_004624747:9,851,153...9,860,094
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to DNA:SNP: :-1023A>G (human) |
ClinVar RGD |
PMID:8383511 PMID:15284533 PMID:16596417 PMID:19638684 |
RGD:4145081 |
NCBI chrNW_004624774:8,211,723...8,215,962
Ensembl chrNW_004624774:8,211,984...8,213,240
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
treatment onset |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:lung (rat) |
RGD CTD |
PMID:21920897 PMID:23304218 PMID:33075463 |
RGD:6767554 RGD:7244279 |
NCBI chrNW_004624754:24,138,086...24,140,900
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
|
RGD |
PMID:17877756 PMID:19080339 |
RGD:5147452 RGD:5147457 |
NCBI chrNW_004624730:25,964,848...26,006,468
Ensembl chrNW_004624730:25,964,811...26,006,463
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19080339 |
RGD:5147457 |
NCBI chrNW_004624967:327,627...332,000
Ensembl chrNW_004624967:329,284...330,372
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9600491 PMID:11506308 |
|
NCBI chrNW_004624747:20,407,190...20,438,605
Ensembl chrNW_004624747:20,403,717...20,438,690
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
treatment no_association severity |
ISO |
DNA:polymorphism:promoter (human) DNA:repeat:promoter (human) |
RGD OMIM |
PMID:10369259 PMID:12911785 PMID:16364163 PMID:20128419 |
RGD:4890407 RGD:4890415 RGD:5147465 RGD:734557 |
NCBI chrNW_004624966:168,244...220,430
Ensembl chrNW_004624966:168,250...220,522
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
susceptibility no_association |
ISO |
DNA:SNPs (human) mRNA:increased expression:blood, leukocyte DNA:substitution, repeat:promoter:-336G>A, -169(A)19-23 (human) DNA:repeat:promoter:-169(A)21 (human) DNA:polymorphisms:intron:IVS2+12C>A, IVS2+105T>C (human) DNA:polymorphism:promoter (human) DNA:SNP: :rs10507391 (human) protein:increased expression:lung |
RGD |
PMID:8879219 PMID:9642160 PMID:10527888 PMID:11035107 PMID:12911785 PMID:15784112 PMID:18547289 PMID:20067482 PMID:20128419 More...
|
RGD:4890405 RGD:4890407 RGD:4890409 RGD:4890422 RGD:5147462 RGD:5147464 RGD:5147465 RGD:5147466 RGD:5147467 |
NCBI chrNW_004624776:7,475,269...7,646,805
Ensembl chrNW_004624776:7,475,200...7,506,283
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14621078 |
RGD:6904149 |
NCBI chrNW_004624760:21,047,576...21,064,698
Ensembl chrNW_004624760:21,047,303...21,068,076
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:22092555 |
RGD:7421657 |
NCBI chrNW_004624811:765,338...782,203
Ensembl chrNW_004624811:764,940...782,198
|
|
G |
Areg |
amphiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15696081 |
|
NCBI chrNW_004624730:1,290,692...1,299,365
Ensembl chrNW_004624730:1,290,655...1,299,410
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
mRNA, protein:increased expression:lung, mononuclear cell (human) DNA:SNP: :rs2781667 (human) mRNA:increased expression:lung (mouse) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12813022 PMID:19281908 PMID:19800904 PMID:20124949 |
RGD:4143187 RGD:5129205 |
NCBI chrNW_004624753:5,737,720...5,749,313
Ensembl chrNW_004624753:5,737,237...5,752,966
|
|
G |
Arg2 |
arginase 2 |
severity susceptibility |
ISO |
mRNA:increased expression:lung (mouse) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs3742879, rs17249437 (human) DNA:SNPs (human) |
RGD CTD |
PMID:12813022 PMID:16387594 PMID:19281908 PMID:20124949 |
RGD:4143187 RGD:5129205 RGD:5129207 |
NCBI chrNW_004624734:33,321,161...33,352,306
Ensembl chrNW_004624734:33,321,295...33,352,277
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18357729 |
|
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
onset |
ISO |
DNA:polymorphism:exon (human) protein:increased expression:blood, eosinophil |
RGD |
PMID:8856156 PMID:11517947 PMID:14727005 PMID:19038786 |
RGD:4890454 RGD:4890456 RGD:4891028 RGD:4891042 |
NCBI chrNW_004624734:8,513,601...8,538,838
Ensembl chrNW_004624734:8,513,814...8,539,036
|
|
G |
Bdnf |
brain derived neurotrophic factor |
severity susceptibility |
ISO |
DNA:polymorphisms: :p.V66M (rs6265) (human) protein:decreased expression:blood, eosinophil protein:increased expression:plasma DNA:polymorphisms: :p.V66M, -270C>T (human) DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) |
RGD |
PMID:11737043 PMID:12752594 PMID:17584309 PMID:19895626 PMID:20874832 PMID:21723144 More...
|
RGD:4891063 RGD:4891067 RGD:4891117 RGD:4891122 RGD:4891123 RGD:8655967 |
NCBI chrNW_004624766:17,281,882...17,330,601
Ensembl chrNW_004624766:17,279,630...17,330,490
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8429434 |
|
NCBI chrNW_004624885:1,526,625...1,528,235
Ensembl chrNW_004624885:1,527,538...1,528,109
|
|
G |
Bmpr1b |
bone morphogenetic protein receptor type 1B |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004624757:22,697,639...23,142,209
Ensembl chrNW_004624757:22,955,666...23,142,499
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004624765:13,849,689...13,950,839
Ensembl chrNW_004624765:13,857,062...13,947,683
|
|
G |
C3 |
complement C3 |
severity |
ISO |
protein:increased expression:serum DNA:SNPs: :multiple (human) DNA:SNP:intron:rs11569562 (human) Interaction with IL4RA protein:increased expression:respiratory system fluid/secretion DNA:SNP: :4896C>T (human) |
RGD |
PMID:11591733 PMID:15278436 PMID:16355111 PMID:18566738 PMID:20395963 PMID:20402389 PMID:20589464 PMID:20802484 More...
|
RGD:5129501 RGD:5129505 RGD:5129512 RGD:5129517 RGD:5129519 RGD:5129537 RGD:5129538 RGD:5129681 |
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
|
|
G |
C3ar1 |
complement C3a receptor 1 |
severity |
ISO |
protein:increased expression:lung, leukocyte mRNA:increased expression:lung |
RGD |
PMID:15278436 PMID:15940127 PMID:17544263 PMID:20045013 PMID:20802484 |
RGD:5129512 RGD:5129560 RGD:5129561 RGD:5129681 RGD:5129686 |
NCBI chrNW_004624860:5,196,621...5,204,686
Ensembl chrNW_004624860:5,197,619...5,199,043
|
|
G |
C5ar1 |
complement C5a receptor 1 |
severity |
ISO |
protein:increased expression:lung, leukocyte protein:increased expression:respiratory tract |
RGD |
PMID:15940127 PMID:16511606 PMID:17544263 PMID:20802484 |
RGD:5129560 RGD:5129561 RGD:5129681 RGD:5130166 |
NCBI chrNW_004624832:6,413,169...6,423,394
Ensembl chrNW_004624832:6,414,587...6,423,394
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma |
RGD ClinVar |
PMID:16751370 PMID:18323416 PMID:23027925 PMID:23129749 PMID:25352053 PMID:25741868 PMID:26861442 PMID:28492532 PMID:28824638 PMID:29472930 More...
|
RGD:11100037 |
NCBI chrNW_004624740:29,974,707...30,085,498
Ensembl chrNW_004624740:29,974,689...30,085,981
|
|
G |
Carm1 |
coactivator associated arginine methyltransferase 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004624828:2,833,011...2,872,281
Ensembl chrNW_004624828:2,832,769...2,871,167
|
|
G |
Cat |
catalase |
severity |
ISO |
DNA:polymorphism:promoter:-21A>T (human) protein:decreased activity protein:increased expression:erythrocyte protein:decreased activity:respiratory system fluid/secretion DNA:polymorphism:promoter:-262C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16622028 PMID:18048809 PMID:19373626 PMID:19475625 |
RGD:5130751 RGD:5130753 RGD:5130856 RGD:5130867 |
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20455898 |
RGD:4891420 |
NCBI chrNW_004624875:2,224,784...2,229,465
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion mRNA:increased expression:lung |
RGD |
PMID:11160256 PMID:15947487 PMID:15993846 PMID:20074456 PMID:20237293 |
RGD:2306304 RGD:4145486 RGD:4145487 RGD:4145513 RGD:4145603 |
NCBI chrNW_004624746:28,655,288...28,657,563
Ensembl chrNW_004624746:28,655,801...28,657,470
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
protein:increased expression:bronchus submucosa, mast cell |
RGD |
PMID:16959919 |
RGD:5130911 |
NCBI chrNW_004624736:39,088,741...39,090,745
Ensembl chrNW_004624736:39,088,921...39,090,394
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion associated with Allergic Rhinitis;protein:increased expression:serum |
RGD |
PMID:18422729 PMID:22469443 |
RGD:7483597 RGD:7483618 |
NCBI chrNW_004624843:2,017,738...2,021,153
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
mRNA:increased expression:lung mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10384142 PMID:15993846 PMID:18316417 PMID:18684970 |
RGD:2306304 RGD:4145489 RGD:4891474 RGD:4891475 |
NCBI chrNW_004624746:28,694,879...28,700,711
Ensembl chrNW_004624746:28,694,735...28,700,827
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
susceptibility |
ISO |
DNA:SNPs: :179T>C, 275C>T (human) protein:increased expression:respiratory system fluid/secretion DNA:SNPs: :304C>A, 1272A>G (human) protein:increased expression:plasma DNA:SNP: :1265A>G (human) |
RGD |
PMID:12761043 PMID:12952266 PMID:15207712 PMID:16304252 PMID:17060636 PMID:17548626 PMID:18712274 More...
|
RGD:4891483 RGD:4891484 RGD:4891485 RGD:4891495 RGD:4891496 RGD:5130930 RGD:5130932 |
NCBI chrNW_004624740:14,640,486...14,652,414
Ensembl chrNW_004624740:14,640,292...14,643,020
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
|
ISO |
|
RGD |
PMID:19541356 |
RGD:5130899 |
NCBI chrNW_004624736:39,055,705...39,056,722
Ensembl chrNW_004624736:39,055,726...39,057,630
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16290206 |
RGD:4892195 |
NCBI chrNW_004624759:11,759,304...11,781,284
Ensembl chrNW_004624759:11,759,048...11,784,493
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:smooth muscle cell DNA:transition:5' utr:-403G>A (human) protein:increased expression:lung, secretion (mouse) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8534483 PMID:18208670 PMID:20092989 PMID:20430255 |
RGD:2307112 RGD:4891381 RGD:4891430 |
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, neutrophil DNA:SNP:exon:51T>C (human) |
RGD |
PMID:16978084 PMID:17145927 PMID:18699933 PMID:19017998 PMID:19657453 PMID:20134116 PMID:20220260 More...
|
RGD:1601020 RGD:4145618 RGD:4145623 RGD:4145632 RGD:4145633 RGD:4145638 RGD:4145646 |
NCBI chrNW_004624730:74,768,668...74,769,749
Ensembl chrNW_004624730:74,768,668...74,769,798
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004624788:10,965,226...10,974,215
Ensembl chrNW_004624788:10,966,207...10,971,180
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004624785:12,190,802...12,203,924
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004624795:2,777,766...2,787,664
Ensembl chrNW_004624795:2,779,627...2,788,897
|
|
G |
Ccr8 |
C-C motif chemokine receptor 8 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004624731:1,634,460...1,635,629
Ensembl chrNW_004624731:1,634,562...1,635,629
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
mRNA, protein:increased expression:blood, mature NK T cell |
RGD |
PMID:16210593 |
RGD:5130925 |
NCBI chrNW_004624730:74,989,725...74,991,400
Ensembl chrNW_004624730:74,990,318...74,996,239
|
|
G |
Cd14 |
CD14 molecule |
severity susceptibility no_association |
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:c. -260C>T (human) protein:increased expression:serum|DNA:polymorphism:promoter:c. -159C>T (human) DNA:SNPs: : |
RGD CTD |
PMID:15741437 PMID:15940135 PMID:16387800 PMID:17607003 PMID:18312481 PMID:19096003 More...
|
RGD:4144208 RGD:4144228 RGD:4144813 RGD:4144814 RGD:4144815 |
NCBI chrNW_004624743:33,372,023...33,374,438
Ensembl chrNW_004624743:33,367,898...33,373,922
|
|
G |
Cd274 |
CD274 molecule |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004624736:9,991,851...10,017,047
Ensembl chrNW_004624736:9,996,156...10,013,814
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21356099 |
RGD:5131612 |
NCBI chrNW_004624765:12,650,092...12,667,168
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:19159017 PMID:19220210 PMID:20205594 PMID:20941750 |
RGD:4144188 RGD:4892277 RGD:5132272 RGD:8547792 |
NCBI chrNW_004624790:8,475,640...8,485,927
Ensembl chrNW_004624790:8,476,158...8,485,856
|
|
G |
Cd40lg |
CD40 ligand |
severity |
ISO |
|
RGD |
PMID:9502776 |
RGD:11352238 |
NCBI chrNW_004624808:10,472,028...10,484,407
Ensembl chrNW_004624808:10,472,572...10,484,338
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:21051864 PMID:21352203 PMID:21440530 |
RGD:5132619 RGD:5132620 RGD:5132621 |
NCBI chrNW_004624731:28,630,540...28,655,297
Ensembl chrNW_004624731:28,630,446...28,651,994
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
protein:increased expression:blood, B cell (human) protein:increased expression:lung, alveolar macrophage (mouse) protein:increased expression:lung, dendritic cell (rat) DNA:snp:exon:p.I179V rs2681417 (human) |
RGD |
PMID:9449507 PMID:9551945 PMID:17513529 PMID:20668438 PMID:20941750 PMID:25344652 More...
|
RGD:11354965 RGD:4892199 RGD:4892202 RGD:4892277 RGD:4892280 RGD:4892555 |
NCBI chrNW_004624912:350,201...432,410
Ensembl chrNW_004624912:350,157...426,712
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
|
RGD |
PMID:21540309 |
RGD:5132878 |
NCBI chrNW_004624746:17,480,472...17,557,722
Ensembl chrNW_004624746:17,483,469...17,557,581
|
|
G |
Cdhr3 |
cadherin related family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004624739:23,629,235...23,693,267
|
|
G |
Cftr |
CF transmembrane conductance regulator |
susceptibility |
ISO |
DNA:deletion: :p.F508del(human) |
RGD |
PMID:20298391 |
RGD:4140387 |
NCBI chrNW_004624827:1,704,733...1,893,579
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
Protein:decreased expression:lung epithelium |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004624928:357,812...401,668
Ensembl chrNW_004624928:360,704...399,714
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 7 |
OMIM ClinVar |
PMID:18403759 |
|
NCBI chrNW_004624807:7,655,777...7,664,484
Ensembl chrNW_004624807:7,655,620...7,662,362
|
|
G |
Chml |
CHM like Rab escort protein |
|
ISO |
|
RGD |
PMID:18343558 |
RGD:5133238 |
NCBI chrNW_004624771:11,981,078...11,987,379
|
|
G |
Chrm1 |
cholinergic receptor muscarinic 1 |
|
ISO |
|
RGD |
PMID:16931638 |
RGD:5133416 |
NCBI chrNW_004624926:1,326,851...1,335,477
Ensembl chrNW_004624926:1,326,866...1,330,805
|
|
G |
Chrm2 |
cholinergic receptor muscarinic 2 |
|
ISO |
DNA:SNP: :rs6962027 (human) |
RGD |
PMID:19308904 |
RGD:5509586 |
NCBI chrNW_004624765:17,211,162...17,342,505
Ensembl chrNW_004624765:17,333,678...17,340,421
|
|
G |
Chrm3 |
cholinergic receptor muscarinic 3 |
severity |
ISO |
|
RGD |
PMID:18348887 PMID:20394512 |
RGD:5133437 RGD:5133438 |
NCBI chrNW_004624775:10,948,075...11,427,898
Ensembl chrNW_004624775:10,949,983...10,951,755
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:21496385 |
RGD:5133703 |
NCBI chrNW_004624737:12,022,081...12,052,128
Ensembl chrNW_004624737:12,022,419...12,052,131
|
|
G |
Clca1 |
chloride channel accessory 1 |
susceptibility |
ISO |
DNA:SNPs (human) |
RGD |
PMID:11296262 PMID:15318163 PMID:17898169 |
RGD:4145653 RGD:4145656 RGD:4145661 |
NCBI chrNW_004624742:11,145,406...11,172,369
Ensembl chrNW_004624742:11,145,413...11,172,369
|
|
G |
Cldn18 |
claudin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27215490 |
|
NCBI chrNW_004624730:14,500,379...14,522,047
Ensembl chrNW_004624730:14,489,585...14,522,042
|
|
G |
Cma1 |
chymase 1 |
susceptibility no_association severity |
ISO |
DNA:duplications:3' utr:g.*254-?dupTG, dupGA (human) DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human) protein:increased expression:lung epithelium, mast cell (human) |
RGD |
PMID:15248847 PMID:15924217 PMID:20813890 |
RGD:1625396 RGD:1625397 RGD:5128804 |
NCBI chrNW_004624820:8,021,965...8,024,763
Ensembl chrNW_004624820:8,021,959...8,024,851
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
DNA:SNP: :RS242941 (human) DNA:SNPs: :rs1876828, rs242939, rs242941 (human) |
RGD |
PMID:16113459 PMID:19663668 |
RGD:5147485 RGD:5147488 |
NCBI chrNW_004624849:2,484,144...2,528,130
Ensembl chrNW_004624849:2,484,109...2,528,223
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:18408560 |
RGD:5130938 |
NCBI chrNW_004624739:114,383...161,010
Ensembl chrNW_004624739:114,342...161,044
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21140796 |
RGD:5131288 |
NCBI chrNW_004624794:1,531,555...1,533,804
Ensembl chrNW_004624794:1,531,571...1,533,804
|
|
G |
Csf2 |
colony stimulating factor 2 |
severity |
ISO |
protein:increased expression:lung protein:increased expression:sputum |
RGD |
PMID:9717963 PMID:19213775 PMID:20405019 |
RGD:10449521 RGD:5131473 RGD:5131476 |
NCBI chrNW_004624733:40,039,127...40,041,294
Ensembl chrNW_004624733:40,039,414...40,041,294
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20405019 PMID:21396376 |
RGD:5131473 RGD:5133731 |
NCBI chrNW_004624795:3,162,999...3,167,248
Ensembl chrNW_004624795:3,163,009...3,166,594
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
severity no_association treatment |
ISO |
DNA:polymorphism:promoter:-318C>T (human) DNA:SNPs: :multiple (human) DNA:SNP: :rs3087243 (human) DNA:polymorphisms:promoter, exon:-318C>T 49A>G (human) DNA:SNPs:promoter, exon:-1147C>T, -318C>T, 49A>G (human) protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11726402 PMID:12114354 PMID:12956753 PMID:15316504 PMID:15871446 PMID:16677453 PMID:16708626 PMID:16926542 PMID:17237396 PMID:17469155 PMID:18699801 PMID:19895365 PMID:28807506 More...
|
RGD:11344922 RGD:4891510 RGD:4891514 RGD:4891516 RGD:4891517 RGD:4891519 RGD:4891521 RGD:4891522 RGD:4891526 RGD:4891527 RGD:4891528 RGD:4891529 |
NCBI chrNW_004624765:12,449,205...12,454,324
Ensembl chrNW_004624765:12,449,205...12,454,324
|
|
G |
Ctnna3 |
catenin alpha 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19187332 |
|
NCBI chrNW_004624754:285,469...2,182,218
Ensembl chrNW_004624754:285,857...2,034,582
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:14657873 |
RGD:4891906 |
NCBI chrNW_004624746:28,677,956...28,688,638
Ensembl chrNW_004624746:28,677,709...28,689,122
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
no_association |
ISO |
DNA:polymorphisms: :p.V249I, p.T280M (human) DNA:SNPs: :p.V249I, rs2669849 (human) |
RGD |
PMID:17082760 PMID:17505143 PMID:21037587 |
RGD:4891882 RGD:4891895 RGD:4891904 |
NCBI chrNW_004624731:1,705,953...1,719,452
Ensembl chrNW_004624731:1,706,043...1,719,452
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11994485 PMID:16602032 PMID:17302903 |
RGD:5135439 RGD:5135452 RGD:5135457 |
NCBI chrNW_004624757:14,989,241...14,991,650
Ensembl chrNW_004624757:14,989,084...14,991,910
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 |
|
NCBI chrNW_004624733:11,455,166...11,463,086
Ensembl chrNW_004624733:11,455,047...11,463,176
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15210824 |
RGD:5135447 |
NCBI chrNW_004624757:14,995,649...15,009,771
Ensembl chrNW_004624757:14,995,716...15,011,893
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
severity susceptibility |
ISO |
protein:decreased expression:respiratory system fluid/secretion, T cell DNA:SNP:intron:IVS1+234G>A (human) |
RGD |
PMID:16043121 PMID:16548899 PMID:17641057 PMID:18094012 |
RGD:4892088 RGD:5135484 RGD:5143932 RGD:5143934 |
NCBI chrNW_004624903:1,958,323...1,961,789
Ensembl chrNW_004624903:1,958,698...1,961,763
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
no_association severity |
ISO |
DNA:SNPs:promoter, exon:multiple (human) mRNA, protein:increased expression:respiratory system mucosa DNA:SNPs:promoter:-634C>T, -475A>C, -336A>G (human) DNA:SNP: :927T>C (human) |
RGD |
PMID:8087328 PMID:11591188 PMID:16123393 PMID:16387808 PMID:16630147 PMID:16771777 PMID:16776674 PMID:17153879 PMID:17689528 More...
|
RGD:4781449 RGD:4781742 RGD:4782072 RGD:4784257 RGD:4843543 RGD:4847129 RGD:4848936 RGD:4888514 RGD:4889116 |
NCBI chrNW_004624836:2,556,269...2,597,008
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:polymorphism: :601A>G (human) DNA:polymorphism: :-1220A>C (human) |
RGD |
PMID:15454733 PMID:15475736 |
RGD:5144002 RGD:5144003 |
NCBI chrNW_004624748:6,040,564...6,043,454
|
|
G |
Dcn |
decorin |
|
ISO |
|
RGD |
PMID:16387756 |
RGD:2311423 |
NCBI chrNW_004624750:15,466,938...15,517,475
Ensembl chrNW_004624750:15,470,968...15,516,365
|
|
G |
Defb1 |
defensin beta 1 |
susceptibility |
ISO |
DNA:SNPs:5' utr:g.-52G>A, g.-44C>G, g.-20G>A (human) DNA:SNP: :-1816 T>C (human) |
RGD |
PMID:15696078 PMID:16435024 |
RGD:4892254 RGD:4892263 |
NCBI chrNW_004624861:4,710,687...4,718,867
|
|
G |
Dnah5 |
dynein axonemal heavy chain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004624751:10,799,102...11,110,180
Ensembl chrNW_004624751:10,799,892...11,050,403
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA,mRNA:hypermethylation,decreased expression:promoter,respiratory tract: |
CTD RGD |
PMID:23196709 PMID:23423710 |
RGD:9588646 |
NCBI chrNW_004624828:2,316,042...2,358,866
Ensembl chrNW_004624828:2,315,251...2,358,711
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
|
ISO |
DNA:SNP:exon (human) protein:increased expression:bronchus DNA:SNP: :rs10208402 (human) DNA:SNPs (human) |
RGD |
PMID:14566338 PMID:17967935 PMID:19672052 PMID:21103062 |
RGD:4889866 RGD:4892275 RGD:4892276 RGD:4892278 |
NCBI chrNW_004624732:29,385,895...30,748,424
Ensembl chrNW_004624732:29,386,401...30,042,127
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
|
ISO |
|
RGD |
PMID:21255010 |
RGD:5128488 |
NCBI chrNW_004624828:5,402,589...5,409,914
Ensembl chrNW_004624828:5,402,961...5,407,891
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:transition:intron:g.4124T>C (human) Severe Persistent Allergic Asthma; protein:increased secretion:lung (human) |
CTD RGD |
PMID:11668616 PMID:16981460 PMID:20588001 |
RGD:4144869 RGD:4144895 |
NCBI chrNW_004624756:13,842,482...13,849,003
Ensembl chrNW_004624756:13,842,164...13,849,029
|
|
G |
Ednra |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:17448648 PMID:18632188 |
RGD:4892288 RGD:4892322 |
NCBI chrNW_004624853:6,298,406...6,362,353
Ensembl chrNW_004624853:6,302,751...6,360,089
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
mRNA:increased expression:bronchus, smooth muscle cell DNA:polymorphism (human) |
RGD |
PMID:15245576 PMID:17470272 PMID:18632188 |
RGD:4892288 RGD:4892321 RGD:4892324 |
NCBI chrNW_004624751:22,459,613...22,491,409
Ensembl chrNW_004624751:22,459,584...22,491,606
|
|
G |
Egfr |
epidermal growth factor receptor |
severity |
ISO |
protein:increased expression:lung epithelium (mouse) protein:increased expression:bronchial epithelium (human) protein:increased expression:lung epithelium (rat) |
RGD |
PMID:12580917 PMID:19954006 PMID:21072743 PMID:21224214 |
RGD:5131468 RGD:5131633 RGD:5131642 RGD:5131870 |
NCBI chrNW_004624740:584,133...713,205
Ensembl chrNW_004624740:589,606...713,271
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) mRNA:increased expression:bronchoalveolar lavage cell (human) |
RGD |
PMID:11254538 PMID:18507785 PMID:18774390 |
RGD:5130915 RGD:5131985 RGD:5131993 |
NCBI chrNW_004624743:31,247,855...31,251,675
Ensembl chrNW_004624743:31,247,516...31,252,205
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
no_association |
ISO |
|
RGD |
PMID:11281413 PMID:12774215 |
RGD:5129157 RGD:5129158 |
NCBI chrNW_004624758:2,575,516...2,646,313
Ensembl chrNW_004624758:2,575,671...2,646,313
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
susceptibility |
ISO |
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human) |
RGD |
PMID:17711870 |
RGD:4889407 |
NCBI chrNW_004624835:6,161,930...6,181,016
Ensembl chrNW_004624835:6,162,111...6,168,714
|
|
G |
Epx |
eosinophil peroxidase |
disease_progression severity |
ISO |
protein:increased activity:sputum,nasal,pharyngeal mucosa |
RGD |
PMID:12199967 PMID:20813885 PMID:26645423 |
RGD:11574908 RGD:13506891 RGD:13506892 |
NCBI chrNW_004624871:40,811...50,436
Ensembl chrNW_004624871:40,885...50,116
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
mRNA:decreased expression:lung (rat) |
RGD |
PMID:18375789 |
RGD:8694127 |
NCBI chrNW_004624734:36,742,913...36,862,993
Ensembl chrNW_004624734:36,759,104...36,825,295
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:plasma associated with Rhinosinusitis, associated with Nasal Polyps;protein:increased expression:nasal mucus |
RGD |
PMID:21658190 PMID:21711961 |
RGD:5147753 RGD:5147783 |
NCBI chrNW_004624767:1,876,974...1,887,720
Ensembl chrNW_004624767:1,877,024...1,887,958
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:19864598 |
RGD:4892589 |
NCBI chrNW_004624869:1,326,605...1,337,195
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004624793:780,057...788,105
Ensembl chrNW_004624793:780,059...788,095
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA:increased expression:eosinophil |
RGD |
PMID:16337971 |
RGD:1600350 |
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
severity |
ISO |
Fatal asthma subjects Asthma symptoms persistent despite steroids |
RGD |
PMID:20937062 PMID:21388666 |
RGD:5128711 RGD:5128717 |
NCBI chrNW_004624794:2,003,031...2,008,930
Ensembl chrNW_004624794:2,002,928...2,008,940
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
|
ISO |
protein:increased expression:alveolar macrophage |
RGD |
PMID:9117017 |
RGD:5147982 |
NCBI chrNW_004624826:23,930...34,735
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:20179765 |
RGD:11344929 |
NCBI chrNW_004624826:97,605...112,101
|
|
G |
Fcgr3a |
Fc fragment of IgG receptor IIIa |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chrNW_004624826:51,387...59,117
|
|
G |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004624858:5,848,817...5,856,448
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
|
ISO |
ClinVar Annotator: match by term: Asthma |
ClinVar |
|
|
NCBI chrNW_004624754:21,825,122...21,930,870
Ensembl chrNW_004624754:21,870,240...21,929,838
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27633092 PMID:27965764 PMID:28944907 PMID:29317916 |
RGD:38548920 RGD:38549365 |
NCBI chrNW_004624893:995,145...1,008,492
Ensembl chrNW_004624893:995,182...1,008,679
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
|
RGD |
PMID:9949310 PMID:18186587 |
RGD:5128802 RGD:5128803 |
NCBI chrNW_004624775:2,985,077...3,014,567
Ensembl chrNW_004624775:2,994,164...3,015,392
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
protein, mRNA:increased expression:bronchoalveolar lavage fluid: |
RGD |
PMID:21169467 |
RGD:5509920 |
NCBI chrNW_004624890:3,274,239...3,318,281
Ensembl chrNW_004624890:3,226,900...3,318,316
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
DNA:polymorphism |
RGD |
PMID:11470996 PMID:17550934 |
RGD:5135038 RGD:5135039 |
NCBI chrNW_004624772:5,495,452...5,498,714
Ensembl chrNW_004624772:5,495,452...5,498,652
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:20628202 |
RGD:5128851 |
NCBI chrNW_004624733:32,284,793...32,310,980
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
|
RGD |
PMID:17517968 |
RGD:5135525 |
NCBI chrNW_004624733:32,521,318...32,527,499
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
mRNA:decreased expression:macrophage: |
RGD |
PMID:20538962 |
RGD:9590321 |
NCBI chrNW_004624856:4,834,197...4,861,546
Ensembl chrNW_004624856:4,834,217...4,861,592
|
|
G |
Hdc |
histidine decarboxylase |
|
ISO |
associated with Rhinitis;DNA:SNP: :p.E644D (rs2073440) (human) |
RGD |
PMID:20608921 |
RGD:5128884 |
NCBI chrNW_004624731:9,835,585...9,856,743
Ensembl chrNW_004624731:9,835,596...9,856,743
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:18160846 |
RGD:10402541 |
NCBI chrNW_004624734:39,414,458...39,471,705
Ensembl chrNW_004624734:39,411,824...39,471,705
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:20084838 |
RGD:5508450 |
NCBI chrNW_004624951:681,559...711,476
Ensembl chrNW_004624951:682,178...711,474
|
|
G |
Hmox1 |
heme oxygenase 1 |
severity |
ISO |
mRNA;protein:increased expression:Leukocytes, Mononuclear CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16196283 PMID:18048809 PMID:20596599 |
RGD:4145403 RGD:4145408 |
NCBI chrNW_004624750:341,699...346,005
Ensembl chrNW_004624750:342,146...345,887
|
|
G |
Hnmt |
histamine N-methyltransferase |
no_association susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD OMIM ClinVar |
PMID:10752634 PMID:10803682 PMID:15693910 PMID:16205835 PMID:17651147 PMID:25741868 More...
|
RGD:5128885 RGD:5128887 RGD:5128888 |
NCBI chrNW_004624732:37,621,014...37,689,873
Ensembl chrNW_004624732:37,620,925...37,691,708
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11932298 |
|
NCBI chrNW_004624746:18,883,587...18,889,205
Ensembl chrNW_004624746:18,883,353...18,889,402
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322896 |
|
NCBI chrNW_004624748:8,154,288...8,223,226
Ensembl chrNW_004624748:8,155,107...8,223,259
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:aorta (mouse) protein:increased secretion:lung (human) protein:increased expression:lung, serum (rat) |
CTD RGD |
PMID:17014439 PMID:20205697 PMID:20400685 PMID:20953388 PMID:25003170 |
RGD:4145331 RGD:4145444 RGD:4145509 |
NCBI chrNW_004624828:2,432,584...2,451,997
Ensembl chrNW_004624828:2,432,550...2,453,071
|
|
G |
Ifng |
interferon gamma |
resistance treatment |
ISO |
protein:increased expression:sputum |
RGD |
PMID:12396623 PMID:19542437 PMID:20817868 PMID:20953328 |
RGD:10755706 RGD:4145525 RGD:4145651 RGD:5128479 |
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 PMID:21737883 |
RGD:6480255 RGD:6480431 |
NCBI chrNW_004624886:618,372...640,954
Ensembl chrNW_004624886:618,289...642,928
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25256354 |
|
NCBI chrNW_004624795:3,222,170...3,347,079
Ensembl chrNW_004624795:3,290,078...3,345,533
|
|
G |
Il10 |
interleukin 10 |
susceptibility treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:plasma DNA:polymorphism: :-627C>A (human) |
RGD CTD |
PMID:12938145 PMID:20121766 PMID:20230687 PMID:20237464 PMID:20560982 PMID:20644177 PMID:21998459 PMID:29317916 More...
|
RGD:11046261 RGD:4140421 RGD:4140451 RGD:4140459 RGD:4140471 RGD:4143221 RGD:5131623 |
NCBI chrNW_004624807:4,687,249...4,691,658
Ensembl chrNW_004624807:4,687,176...4,691,732
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
|
RGD |
PMID:17056578 PMID:17548618 |
RGD:4373570 RGD:4438438 |
NCBI chrNW_004624730:37,787,772...37,794,871
Ensembl chrNW_004624730:37,787,909...37,794,940
|
|
G |
Il12b |
interleukin 12B |
severity susceptibility |
ISO |
DNA:polymorphisms:introns: ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphisms:promoter, 3'utr: DNA:polymorphism:promoter |
RGD ClinVar |
PMID:12241719 PMID:15322986 PMID:16210052 |
RGD:1600043 RGD:4145428 RGD:4145438 |
NCBI chrNW_004624733:30,146,050...30,156,144
Ensembl chrNW_004624733:30,146,050...30,154,589
|
|
G |
Il13 |
interleukin 13 |
susceptibility severity no_association |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphism: :c.-1055C>T (human) DNA:polymorphism:cds:p.R130Q (human) protein:increased expression:serum protein:increased expression:sputum |
OMIM ClinVar RGD |
PMID:10699178 PMID:11588017 PMID:11678850 PMID:11709756 PMID:11758895 PMID:12847555 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 PMID:15879126 PMID:18258919 PMID:18328894 PMID:20198887 More...
|
RGD:4145593 RGD:4145639 RGD:4145777 RGD:4763153 RGD:4763761 |
NCBI chrNW_004624733:39,427,189...39,430,019
Ensembl chrNW_004624733:39,428,095...39,429,843
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
no_association |
ISO |
mRNA:increased expression:bronchus DNA:polymorphism: :1050C>T (human) DNA:polymorphisms:promoter, 3' utr:-281T>G, 1365A>G (human) DNA:polymorphism: :1398A>G (human) |
RGD |
PMID:10686479 PMID:11714828 PMID:17006604 PMID:17392323 PMID:18480254 PMID:20383033 More...
|
RGD:4892639 RGD:4892646 RGD:4892647 RGD:4892650 RGD:4892654 RGD:4892655 |
NCBI chrNW_004624895:2,706,225...2,763,489
Ensembl chrNW_004624895:2,706,043...2,763,798
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum mRNA:increased expression:bronchus |
RGD |
PMID:17885690 PMID:20383033 PMID:21462799 |
RGD:4892646 RGD:4892649 RGD:8549521 |
NCBI chrNW_004624940:825,368...842,268
Ensembl chrNW_004624940:819,854...842,284
|
|
G |
Il15 |
interleukin 15 |
no_association |
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:11160248 PMID:15131572 PMID:15843549 PMID:16629787 PMID:19133918 |
RGD:4984421 RGD:4990462 RGD:5000757 RGD:5000758 RGD:5000760 |
NCBI chrNW_004624853:1,059,625...1,144,799
Ensembl chrNW_004624853:1,128,519...1,144,941
|
|
G |
Il16 |
interleukin 16 |
no_association severity |
ISO |
DNA:SNP:promoter:-295T>C (human) protein:increased expression:serum associated with Rhinitis;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10585533 PMID:12872394 PMID:15784111 PMID:16387589 PMID:16734115 |
RGD:5024928 RGD:5024930 RGD:5024934 RGD:5024935 RGD:5024937 |
NCBI chrNW_004624768:20,597,560...20,704,437
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
protein:increased expression:alveolar macrophage DNA:SNP:promoter:rs2275913 (human) mRNA,protein:increased expression:Leukocytes, Mononuclear, lung, serum protein:increased expression:sputum |
RGD |
PMID:15730730 PMID:18060619 PMID:18941201 PMID:20351038 PMID:20437253 |
RGD:4839043 RGD:4888527 RGD:4889114 RGD:4889139 RGD:4889152 |
NCBI chrNW_004624855:3,911,349...3,914,214
Ensembl chrNW_004624855:3,911,349...3,913,136
|
|
G |
Il17rb |
interleukin 17 receptor B |
|
ISO |
associated with Picornaviridae Infections |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004624822:3,339,236...3,355,278
Ensembl chrNW_004624822:3,337,940...3,355,199
|
|
G |
Il18 |
interleukin 18 |
susceptibility severity disease_progression |
ISO |
DNA:SNP:promoter:c.and -137G>C (rs187238)(human) DNA:SNP:promoter: c.-380C>G (rs5744247)(human) DNA:SNPs:Promoter:c. -607C>A (rs1946518), -137G/C (rs187238) (human) protein:increased expression:serum DNA:polymorphism: :c. -105A>C (human) |
RGD |
PMID:11174201 PMID:16433859 PMID:17767553 PMID:18200581 PMID:18826499 PMID:19745201 PMID:20497957 More...
|
RGD:4889585 RGD:4889863 RGD:4889898 RGD:4889900 RGD:4889908 RGD:4889910 RGD:4889923 |
NCBI chrNW_004624784:7,294,286...7,312,959
Ensembl chrNW_004624784:7,294,183...7,304,687
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
DNA:SNP: :rs3771166 (human) DNA:SNPs: :multiple (human) |
RGD |
PMID:11972614 PMID:18382474 PMID:18774397 PMID:19910030 PMID:20860503 |
RGD:5024942 RGD:5024945 RGD:5024946 RGD:5024947 RGD:5024948 |
NCBI chrNW_004624749:6,875,934...6,909,702
Ensembl chrNW_004624749:6,875,750...6,909,734
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
protein:increased expression:serum mRNA, protein:increased expression:lung, serum |
RGD |
PMID:15557163 |
RGD:5037236 |
NCBI chrNW_004624807:4,636,357...4,641,022
Ensembl chrNW_004624807:4,636,374...4,641,022
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:polymorphisms: : |
RGD |
PMID:18763028 |
RGD:4142802 |
NCBI chrNW_004624749:12,795,967...12,805,658
Ensembl chrNW_004624749:12,795,946...12,805,154
|
|
G |
Il1b |
interleukin 1 beta |
susceptibility |
ISO |
DNA:polymorphism: :-511C>T (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:neutrophil |
RGD CTD |
PMID:9176529 PMID:18926055 PMID:19684087 PMID:19842845 |
RGD:4142830 RGD:4142836 RGD:4142864 |
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
severity susceptibility |
ISO |
protein:increased expression:serum DNA:SNP: :rs1420101 (human) DNA:SNP: :rs1041973 (human) DNA:SNP: :rs10197862 (human) DNA:SNPs:intron:rs1420089, rs1861245,rs1946131 (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11463601 PMID:17407196 PMID:17623648 PMID:19179489 PMID:19198610 PMID:19852851 PMID:21150878 PMID:21281963 PMID:21804549 PMID:24241537 PMID:27472835 More...
|
RGD:5144235 RGD:5144237 RGD:5144239 RGD:5144240 RGD:5144242 RGD:5144243 RGD:5144244 RGD:5144245 |
NCBI chrNW_004624749:6,795,822...6,873,068
Ensembl chrNW_004624749:6,795,748...6,873,701
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility severity |
ISO |
DNA, protein:repeat, decreased expression (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs447713, rs3087271 (human) protein:increased expression:plasma DNA:SNPs: :multiple (human) DNA:polymorphism:intron (human) DNA:SNP: :rs2234678 (human) |
RGD CTD |
PMID:9176529 PMID:10843772 PMID:11027520 PMID:15020290 PMID:16409203 PMID:16724092 PMID:17107994 PMID:18763028 PMID:18926055 More...
|
RGD:4142802 RGD:4142864 RGD:4143163 RGD:4143208 RGD:4143209 RGD:4143216 RGD:4143224 RGD:4143225 |
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
|
|
G |
Il2 |
interleukin 2 |
susceptibility |
ISO |
DNA:SNP:promoter:rs2069762(human) |
RGD |
PMID:16333313 PMID:20926789 |
RGD:4889118 RGD:8663473 |
NCBI chrNW_004624777:2,885,537...2,890,453
Ensembl chrNW_004624777:2,885,535...2,890,453
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
DNA:SNP:exon:5250C>T (human) |
RGD |
PMID:18802358 |
RGD:5147396 |
NCBI chrNW_004624777:3,054,368...3,061,304
Ensembl chrNW_004624777:3,054,368...3,061,304
|
|
G |
Il22 |
interleukin 22 |
treatment severity |
ISO |
protein:increased expression:serum mRNA:increased expression:blood, mononuclear cell |
RGD |
PMID:21297073 PMID:21535180 PMID:21998459 |
RGD:11046261 RGD:5147403 RGD:5147409 |
NCBI chrNW_004624802:46,585...51,095
Ensembl chrNW_004624802:46,585...51,095
|
|
G |
Il23r |
interleukin 23 receptor |
|
ISO |
|
RGD |
PMID:19935773 |
RGD:5037240 |
NCBI chrNW_004624742:27,899,934...27,954,145
Ensembl chrNW_004624742:27,901,071...27,941,109
|
|
G |
Il25 |
interleukin 25 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004624820:9,188,709...9,192,180
Ensembl chrNW_004624820:9,188,612...9,191,990
|
|
G |
Il27 |
interleukin 27 |
treatment susceptibility |
ISO |
protein:increased expression:sputum DNA:SNP: :g.-964A>G (human) |
RGD |
PMID:17318299 PMID:17878337 PMID:19542437 PMID:20817868 PMID:26595888 |
RGD:11076728 RGD:4145651 RGD:5128479 RGD:5128485 RGD:5128491 |
NCBI chrNW_004624782:13,009,450...13,015,548
Ensembl chrNW_004624782:13,009,564...13,015,440
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:16081811 |
RGD:5128496 |
NCBI chrNW_004624901:1,274,753...1,288,783
Ensembl chrNW_004624901:1,274,840...1,287,861
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17351063 PMID:20525707 PMID:21377197 |
RGD:2325990 RGD:5147437 RGD:5147445 |
NCBI chrNW_004624775:927,337...991,062
Ensembl chrNW_004624775:924,648...942,354
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
|
ISO |
DNA:SNP: :rs2284033 (human) |
RGD |
PMID:18641329 PMID:20860503 |
RGD:5024942 RGD:5147447 |
NCBI chrNW_004624752:10,662,053...10,682,891
Ensembl chrNW_004624752:10,672,432...10,683,045
|
|
G |
Il33 |
interleukin 33 |
treatment severity |
ISO |
associated with viral pneumonia; associated with fungal infectious disease CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19198610 PMID:21804549 PMID:24241537 PMID:25746970 PMID:27472835 PMID:28947081 PMID:29067999 More...
|
RGD:39938968 RGD:39939002 |
NCBI chrNW_004624736:10,733,944...10,786,188
Ensembl chrNW_004624736:10,764,486...10,784,864
|
|
G |
Il4 |
interleukin 4 |
no_association treatment |
ISO |
DNA:SNP: :589C>T (human) DNA:polymorphism (human) mRNA, protein:increase expression:leukocyte, serum mRNA:increased expression:lung, spleen CTD Direct Evidence: marker/mechanism protein:increased expression:respiratory system fluid/secretion protein:increased expression:lung |
RGD CTD |
PMID:18211752 PMID:18357729 PMID:20524005 PMID:21103062 PMID:21354484 PMID:21364926 PMID:21375458 PMID:24450480 PMID:24946644 More...
|
RGD:10402791 RGD:10402799 RGD:2317290 RGD:4889866 RGD:5128500 RGD:5128502 RGD:5128557 RGD:5128560 |
NCBI chrNW_004624733:39,412,800...39,420,079
|
|
G |
Il4r |
interleukin 4 receptor |
susceptibility severity disease_progression |
ISO |
protein:increased secretion:plasma OMIM:600807 DNA:polymorphism::-1902G/A (human) DNA:SNPs:cds:p. I75V, Q576R (human) DNA:polymorphism:cds:p.I50V (human) DNA:SNPs:cds:p.E375A, Q551R (human) DNA:polymorphism:cds:p. S478P (human) DNA:mutation:cds:p.Q576R (mouse) DNA:SNPs: :multiple DNA:polymorphism:cds:p.Q551R (human) DNA:polymorphism:cds:p.Q576R (human) |
RGD MouseDO |
PMID:11398072 PMID:11709756 PMID:12133990 PMID:12940513 PMID:15479272 PMID:16917945 PMID:17170387 PMID:17586032 PMID:17823973 PMID:18425216 PMID:19770271 PMID:20605987 PMID:20868478 PMID:20953944 More...
|
RGD:4890003 RGD:4890024 RGD:4890346 RGD:4890347 RGD:4890348 RGD:4890349 RGD:4890351 RGD:4890352 RGD:4890387 RGD:4890402 RGD:4890404 RGD:4890406 RGD:5128514 RGD:5128553 |
NCBI chrNW_004624782:11,981,781...12,008,362
|
|
G |
Il5 |
interleukin 5 |
treatment disease_progression |
ISO |
protein: increased levels: sputum DNA:polymorphism:promoter:-703C>T (human) protein:increased expression:respiratory system fluid/secretion protein:increased expression:lungs, respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:7540862 PMID:9182686 PMID:9493449 PMID:11159041 PMID:15502111 PMID:15626484 PMID:17074272 PMID:18629290 PMID:19947994 PMID:22085848 PMID:22186238 PMID:23266719 PMID:25008888 More...
|
RGD:11354973 RGD:4145461 RGD:4890938 RGD:4890940 RGD:4890947 RGD:4890948 RGD:4890962 RGD:4890963 RGD:5687140 RGD:5687144 RGD:5687189 |
NCBI chrNW_004624733:39,544,487...39,558,943
Ensembl chrNW_004624733:39,556,797...39,559,119
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
DNA:SNP: :c.25091G>A (human) DNA:SNPs (human) |
RGD |
PMID:10224351 PMID:10848907 PMID:16217591 PMID:17276963 PMID:20513521 PMID:20592918 More...
|
RGD:5128614 RGD:5128617 RGD:5128623 RGD:5128625 RGD:5128626 RGD:5128627 |
NCBI chrNW_004624773:13,309,888...13,347,318
Ensembl chrNW_004624773:13,311,583...13,347,315
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung associated with Hypersensitivity;protein:increased expression:sputum |
CTD RGD |
PMID:20658762 PMID:20816188 PMID:20840469 PMID:21115736 PMID:29902480 |
RGD:4143265 RGD:4143266 RGD:4143271 RGD:5128630 |
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17496315 PMID:21115736 PMID:29902480 |
RGD:5128630 RGD:5128662 |
NCBI chrNW_004624885:2,910,367...2,946,916
Ensembl chrNW_004624885:2,910,112...2,946,886
|
|
G |
Il9 |
interleukin 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion protein:increased expression:sputum, macrophage, cytoplasm |
RGD |
PMID:12153980 PMID:15303135 PMID:15531759 PMID:17446528 PMID:21356110 |
RGD:5128686 RGD:5128690 RGD:5128691 RGD:5128700 RGD:5128707 |
NCBI chrNW_004624733:11,226,769...11,229,461
Ensembl chrNW_004624733:11,226,769...11,229,461
|
|
G |
Il9r |
interleukin 9 receptor |
|
ISO |
|
RGD |
PMID:10629460 |
RGD:5128704 |
NCBI chrNW_004624913:906,953...918,906
Ensembl chrNW_004624913:908,644...920,658
|
|
G |
Irak3 |
interleukin 1 receptor associated kinase 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 5 |
OMIM ClinVar |
PMID:17503328 |
|
NCBI chrNW_004624802:2,042,486...2,098,921
Ensembl chrNW_004624802:2,047,409...2,098,545
|
|
G |
Irf1 |
interferon regulatory factor 1 |
no_association susceptibility |
ISO |
DNA:polymorphisms:promoter, cds:-300G>T, 4396A>G, 6355G>A (human) DNA:repeat:intron (human) protein:increased expression:respiratory tract epithelium |
RGD |
PMID:10225979 PMID:11069564 PMID:16961714 |
RGD:5128723 RGD:5128724 RGD:5128726 |
NCBI chrNW_004624733:39,596,565...39,603,428
Ensembl chrNW_004624733:39,596,501...39,603,526
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20673978 |
RGD:5128793 |
NCBI chrNW_004624832:4,611,445...4,616,319
Ensembl chrNW_004624832:4,612,374...4,616,276
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:17556058 |
RGD:5037230 |
NCBI chrNW_004624849:1,895,378...1,952,755
Ensembl chrNW_004624849:1,895,914...1,952,665
|
|
G |
Itgb6 |
integrin subunit beta 6 |
|
ISO |
OMIM:600807 |
MouseDO |
|
|
NCBI chrNW_004624732:5,348,589...5,499,826
Ensembl chrNW_004624732:5,403,956...5,499,855
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor type 1 |
|
ISO |
|
RGD |
PMID:21777465 |
RGD:5147661 |
NCBI chrNW_004624773:14,856,803...15,193,173
Ensembl chrNW_004624773:14,856,804...15,193,168
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
associated with Rhinitis,Allergic,Seasonal;protein:increased expression:nasal cavity of mucosa: |
RGD |
PMID:17651148 PMID:20921519 |
RGD:5684385 RGD:8551771 |
NCBI chrNW_004624761:14,330,224...14,380,680
Ensembl chrNW_004624761:14,330,489...14,379,051
|
|
G |
Kif3a |
kinesin family member 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004624733:39,354,360...39,406,574
Ensembl chrNW_004624733:39,354,232...39,407,121
|
|
G |
Lep |
leptin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19705789 |
RGD:5128781 |
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
|
|
G |
Lgals3 |
galectin 3 |
treatment |
ISO |
|
RGD |
PMID:16424226 |
RGD:9685213 |
NCBI chrNW_004624731:14,300,138...14,307,843
Ensembl chrNW_004624731:14,298,201...14,304,637
|
|
G |
LOC101697345 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: : DNA:haplotype |
CTD RGD |
PMID:16792590 PMID:17956852 PMID:21217921 PMID:21814517 |
RGD:13506911 RGD:5143938 |
NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663
|
|
G |
LOC101698463 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:21814517 |
RGD:13506911 |
NCBI chrNW_004624754:23,674,935...23,683,044
Ensembl chrNW_004624754:23,674,448...23,683,662
|
|
G |
LOC101703821 |
HLA class II histocompatibility antigen, DQ beta 1 chain |
no_association susceptibility disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism Alternaria sensitive asthma DNA:polymorphisms: : DNA:polymorphisms (human) |
CTD RGD |
PMID:10792356 PMID:11802952 PMID:12890388 PMID:19052351 PMID:20159242 PMID:20214848 PMID:20298583 PMID:23331206 More...
|
RGD:13506906 RGD:13506913 RGD:4144113 RGD:4144181 RGD:5147617 RGD:5147799 RGD:5147831 |
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
|
|
G |
LOC101706353 |
HLA class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:20159242 |
RGD:13506913 |
NCBI chrNW_004624754:24,079,459...24,086,342
Ensembl chrNW_004624754:24,079,366...24,084,512
|
|
G |
LOC101707509 |
cytochrome P450 1A1 |
|
ISO |
mRNA, protein:increased expression, decreased activity:lung |
RGD |
PMID:12415424 |
RGD:4892074 |
NCBI chrNW_004627988:7...1,323
|
|
G |
LOC101717043 |
cytochrome b-245 light chain |
susceptibility |
ISO |
DNA:polymorphism: :-930A>G (human) DNA:SNPs: :-930A>G, 242C>T, 640A>G (human) |
RGD |
PMID:18716406 PMID:19459419 |
RGD:4311041 RGD:4772770 |
NCBI chrNW_004624746:911,852...919,361
Ensembl chrNW_004624746:911,842...919,362
|
|
G |
LOC101722366 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:leukocyte |
CTD RGD |
PMID:17081494 PMID:20514434 PMID:28807506 |
RGD:4892076 RGD:4892220 |
NCBI chrNW_004624737:12,335,733...12,345,278
Ensembl chrNW_004624737:12,335,681...12,345,514
|
|
G |
LOC101724812 |
C-C chemokine receptor type 1 |
severity |
ISO |
associated with Respiratory Syncytial Virus Infections mRNA:increased expression:lung |
RGD |
PMID:15593301 PMID:15654816 |
RGD:5688158 RGD:5688159 |
NCBI chrNW_004624730:74,822,848...74,828,614
Ensembl chrNW_004624730:74,826,659...74,827,726
|
|
G |
Lta |
lymphotoxin alpha |
no_association susceptibility |
ISO |
DNA:polymorphism:intron DNA:polymorphisms:promoter |
RGD |
PMID:12530118 PMID:15969671 PMID:17536219 PMID:18947013 |
RGD:4143254 RGD:4143370 RGD:4143371 RGD:4143373 |
NCBI chrNW_004624754:24,626,930...24,628,412
Ensembl chrNW_004624754:24,627,318...24,628,182
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
ISO |
mRNA:increased expression:lung, cerebral cortex (rat) |
RGD |
PMID:15715933 |
RGD:2316607 |
NCBI chrNW_004624750:11,274,506...11,314,683
Ensembl chrNW_004624750:11,274,664...11,314,581
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
associated with Bronchiolitis;DNA:polymorphism:exon: DNA:SNP:cds:p.G54D(human) |
RGD |
PMID:22512728 PMID:22674410 |
RGD:12910828 RGD:8693709 |
NCBI chrNW_004624791:10,881,319...10,886,294
Ensembl chrNW_004624791:10,881,268...10,886,297
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
susceptibility |
ISO |
DNA:mutations:exons |
RGD |
PMID:18219832 |
RGD:5129186 |
NCBI chrNW_004624824:1,035,172...1,047,632
Ensembl chrNW_004624824:1,035,094...1,047,678
|
|
G |
Mif |
macrophage migration inhibitory factor |
severity |
ISO |
protein:increased expression:bronchoalveolar lavage fluid DNA:SNP:promoter:rs755622(human) DNA:repeats:promoter |
RGD |
PMID:9637721 PMID:16186482 PMID:16455830 PMID:17373669 PMID:19317738 |
RGD:1641985 RGD:4891035 RGD:4891043 RGD:4891052 RGD:4891059 |
NCBI chrNW_004624747:10,307,826...10,308,649
Ensembl chrNW_004624747:10,303,919...10,308,821
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24469321 |
|
NCBI chrNW_004624878:71,642...79,660
Ensembl chrNW_004624878:71,642...79,602
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004624878:107,330...117,654
Ensembl chrNW_004624878:107,361...117,459
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:serum mRNA, protein:increased expression:lung DNA:SNP: : rs2664538(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11742282 PMID:15131573 PMID:16191269 PMID:19361849 PMID:19940022 PMID:20181264 PMID:21439806 More...
|
RGD:2325953 RGD:5129204 RGD:5129522 RGD:5129687 RGD:5130859 |
NCBI chrNW_004624790:8,584,399...8,591,763
Ensembl chrNW_004624790:8,583,457...8,591,713
|
|
G |
Mpo |
myeloperoxidase |
susceptibility |
ISO |
DNA:polymorphism: :−463G > A (human) protein:increased expression:serum |
RGD |
PMID:10731862 PMID:19544176 |
RGD:5130989 RGD:5130994 |
NCBI chrNW_004624871:121,026...131,433
Ensembl chrNW_004624871:121,026...131,323
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
susceptibility |
ISO |
Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G DNA:SNPs: : rs556917, rs502581, rs502419 (human) DNA:SNP: : -109C>T (human) DNA:SNPs:multiple:, rs573790, rs2583476, rs569108 |
RGD |
PMID:8817330 PMID:19218813 PMID:19862939 PMID:21320344 |
RGD:1599903 RGD:5131092 RGD:5131149 RGD:5131151 |
NCBI chrNW_004624864:804,950...813,419
Ensembl chrNW_004624864:807,253...813,381
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
DNA:transition:cds:g.677C>T (human) |
RGD |
PMID:20456312 |
RGD:4891145 |
NCBI chrNW_004624818:1,184,736...1,202,708
Ensembl chrNW_004624818:1,187,869...1,199,168
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:11802251 |
RGD:5131281 |
NCBI chrNW_004624885:2,339,281...2,343,351
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
associated with hypersensitivity |
RGD |
PMID:11062147 PMID:14594655 |
RGD:5131178 RGD:7349354 |
NCBI chrNW_004624766:21,493,125...21,522,535
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
treatment |
ISO |
mRNA,protein:increased expression:lung mRNA, protein:increased expression:lung |
RGD |
PMID:14594655 PMID:17590487 PMID:17698377 PMID:21549818 PMID:21780541 |
RGD:2324962 RGD:5131204 RGD:7349354 RGD:7349407 RGD:7364729 |
NCBI chrNW_004624766:21,439,023...21,461,108
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:sputum |
RGD |
PMID:11587997 PMID:11802783 |
RGD:5131252 RGD:7364763 |
NCBI chrNW_004624766:21,398,595...21,425,755
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004624886:2,455,704...2,489,593
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
ameliorates |
ISO |
|
RGD |
PMID:26882889 |
RGD:11531666 |
NCBI chrNW_004624731:2,677,259...2,681,408
Ensembl chrNW_004624731:2,677,290...2,681,489
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
|
RGD |
PMID:17472811 |
RGD:4891492 |
NCBI chrNW_004624912:1,952,053...2,213,196
Ensembl chrNW_004624912:1,953,838...2,172,561
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
severity |
ISO |
mRNA:increased expression:bronchoalveolar lavage cell, peripheral blood mononuclear cell (human) |
RGD |
PMID:21514635 |
RGD:6893376 |
NCBI chrNW_004624787:14,355,330...14,381,353
Ensembl chrNW_004624787:14,355,791...14,381,251
|
|
G |
Ngf |
nerve growth factor |
severity |
ISO |
protein:increased expression:blood, eosinophil protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:12752594 PMID:17164945 PMID:17497413 |
RGD:4891068 RGD:4891108 RGD:4891122 RGD:4891123 |
NCBI chrNW_004624772:11,009,765...11,070,050
Ensembl chrNW_004624772:11,010,845...11,070,017
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
|
RGD |
PMID:12540484 PMID:16603479 |
RGD:5144070 RGD:5144072 |
NCBI chrNW_004624795:5,623,686...5,639,545
Ensembl chrNW_004624795:5,623,700...5,639,655
|
|
G |
Nod1 |
nucleotide binding oligomerization domain containing 1 |
susceptibility |
ISO |
DNA:insertion:cds: DNA:SNP: :rs2075817 (human) |
RGD |
PMID:15718249 PMID:16918516 |
RGD:5131518 RGD:5131519 |
NCBI chrNW_004624739:285,791...339,752
Ensembl chrNW_004624739:285,689...341,956
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon/3'UTR (rs1077861, rs3135500) (human) |
RGD |
PMID:16008671 PMID:21051079 |
RGD:5131477 RGD:5508757 |
NCBI chrNW_004624757:5,956,873...6,000,052
Ensembl chrNW_004624757:5,958,486...6,000,103
|
|
G |
Nos1 |
nitric oxide synthase 1 |
susceptibility |
ISO |
DNA:repeats: : DNA:repeats:exon DNA:repeats:intron |
RGD |
PMID:10673365 PMID:10833424 PMID:14767694 PMID:20609134 |
RGD:5132615 RGD:5132860 RGD:5132863 RGD:5132869 |
NCBI chrNW_004624747:15,940,614...16,118,051
Ensembl chrNW_004624747:16,003,969...16,113,165
|
|
G |
Nos2 |
nitric oxide synthase 2 |
severity disease_progression no_association |
ISO |
DNA:repeats:promoter, introns (human) protein:increased expression:lung, bronchoalveolar lavage fluid protein:increased expression, increased activity:lung (rat) mRNA:increased expression:monocyte DNA:repeat:promoter DNA:SNP:exon:p.S608L (human) CTD Direct Evidence: marker/mechanism associated with Rhinitis, Allergic, Seasonal; protein:increased expression:nasal mucosa |
RGD CTD |
PMID:16540403 PMID:16703578 PMID:17161822 PMID:17177683 PMID:17189532 PMID:18254476 PMID:18714530 PMID:19800904 PMID:20841959 PMID:20842520 PMID:21847581 More...
|
RGD:4891419 RGD:4891480 RGD:4891508 RGD:4891910 RGD:4891924 RGD:4891925 RGD:4891927 RGD:4891953 RGD:4891957 RGD:5509073 |
NCBI chrNW_004624786:491,944...530,427
Ensembl chrNW_004624786:489,311...528,271
|
|
G |
Nos3 |
nitric oxide synthase 3 |
susceptibility |
ISO |
DNA:repeats:intron DNA:polymorphisms:promoter:c. -786C>T, -691C>T (human) DNA:snps, repeat, haplotype:promoter, introns, exons:multiple (human) |
RGD |
PMID:16081038 PMID:16837812 PMID:18486767 |
RGD:4892053 RGD:4892058 RGD:4892062 |
NCBI chrNW_004624800:5,600,215...5,619,020
Ensembl chrNW_004624800:5,600,212...5,619,004
|
|
G |
Npy |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chrNW_004624739:6,277,704...6,285,454
Ensembl chrNW_004624739:6,277,612...6,285,397
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
susceptibility |
ISO |
DNA:SNP:exon:c. 609C>T (human) DNA:SNP:exon:c.609C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19027876 PMID:19591959 PMID:20049212 |
RGD:5135005 RGD:5135006 |
NCBI chrNW_004624746:16,684,620...16,698,194
Ensembl chrNW_004624746:16,684,407...16,697,479
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
treatment severity susceptibility |
ISO |
protein:increased expression, decreased activity:leukocyte, mononuclear DNA:polymorphism:intron |
RGD |
PMID:15295049 PMID:18396779 PMID:18799869 PMID:20727335 PMID:21113676 PMID:28297812 More...
|
RGD:408364991 RGD:4892328 RGD:4892568 RGD:4892594 RGD:4892609 RGD:7174728 |
NCBI chrNW_004624774:2,496,276...2,603,894
Ensembl chrNW_004624774:2,495,304...2,602,632
|
|
G |
Ntf3 |
neurotrophin 3 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:17497413 |
RGD:4891068 RGD:4891123 |
NCBI chrNW_004624860:2,416,448...2,479,216
Ensembl chrNW_004624860:2,416,503...2,479,225
|
|
G |
Ntf4 |
neurotrophin 4 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:17497413 |
RGD:4891068 |
NCBI chrNW_004624832:5,005,935...5,008,694
Ensembl chrNW_004624832:5,007,801...5,008,451
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:16708804 PMID:20934630 |
RGD:5684766 RGD:5684772 |
NCBI chrNW_004624885:1,989,027...2,005,474
Ensembl chrNW_004624885:1,989,138...2,005,577
|
|
G |
Ormdl3 |
ORMDL sphingolipid biosynthesis regulator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 PMID:25256354 |
|
NCBI chrNW_004624795:3,210,382...3,216,130
Ensembl chrNW_004624795:3,209,605...3,217,539
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
ISO |
|
RGD |
PMID:19822647 PMID:22010907 |
RGD:6480532 RGD:6480533 |
NCBI chrNW_004624730:28,771,020...28,819,179
Ensembl chrNW_004624730:28,772,525...28,782,431
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activation:lung, blood, mononuclear cell |
CTD RGD |
PMID:12594058 PMID:18261157 PMID:26205779 |
RGD:11073727 RGD:5683910 |
NCBI chrNW_004624807:446,662...478,571
Ensembl chrNW_004624807:446,647...479,069
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004624847:5,732,922...5,741,908
Ensembl chrNW_004624847:5,732,767...5,742,269
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004624742:28,557,159...29,113,269
Ensembl chrNW_004624742:28,557,283...29,016,844
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
protein: increased expression |
RGD |
PMID:21216974 |
RGD:6483071 |
NCBI chrNW_004624752:9,072,471...9,088,289
Ensembl chrNW_004624752:9,072,512...9,088,593
|
|
G |
Pgf |
placental growth factor |
|
ISO |
|
RGD |
PMID:22268141 |
RGD:6483605 |
NCBI chrNW_004624734:26,751,986...26,764,154
Ensembl chrNW_004624734:26,751,530...26,764,242
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:18754810 |
RGD:6482695 |
NCBI chrNW_004624739:22,737,376...22,772,696
Ensembl chrNW_004624739:22,737,270...22,772,589
|
|
G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
ISO |
|
RGD |
PMID:18188456 |
RGD:8693422 |
NCBI chrNW_004624828:2,121,262...2,131,645
Ensembl chrNW_004624828:2,121,329...2,131,645
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
|
RGD |
PMID:15557087 |
RGD:1642462 |
NCBI chrNW_004624814:6,597,248...6,744,294
Ensembl chrNW_004624814:6,597,005...6,744,286
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10733466 |
RGD:1581025 |
NCBI chrNW_004624754:13,905,084...13,932,366
Ensembl chrNW_004624754:13,904,797...13,931,670
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18519237 PMID:21912604 |
RGD:4892037 |
NCBI chrNW_004624754:7,405,637...7,415,870
Ensembl chrNW_004624754:7,408,983...7,416,559
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22205926 |
|
NCBI chrNW_004624733:38,012,694...38,033,745
Ensembl chrNW_004624733:38,012,392...38,036,914
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:21426642 PMID:22250087 |
RGD:6482815 RGD:6482818 |
NCBI chrNW_004624754:4,679,451...4,681,627
Ensembl chrNW_004624754:4,679,521...4,681,627
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004624832:4,593,594...4,602,514
Ensembl chrNW_004624832:4,589,743...4,602,402
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004624745:31,680,149...31,701,322
Ensembl chrNW_004624745:31,689,868...31,709,018
|
|
G |
Prmt3 |
protein arginine methyltransferase 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004624766:11,669,732...11,797,133
Ensembl chrNW_004624766:11,670,108...11,795,272
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004624820:9,599,867...9,608,578
Ensembl chrNW_004624820:9,599,734...9,608,703
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:26381519 |
RGD:11099992 |
NCBI chrNW_004624732:13,915,361...13,922,182
Ensembl chrNW_004624732:13,915,402...13,923,593
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17982072 |
|
NCBI chrNW_004624791:13,975,235...14,056,900
|
|
G |
Ptgdr |
prostaglandin D2 receptor |
susceptibility |
ISO |
|
OMIM |
|
|
NCBI chrNW_004624731:16,776,050...16,785,178
Ensembl chrNW_004624731:16,777,678...16,785,130
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: therapeutic Aspirin exacerbated asthma |
CTD RGD |
PMID:18757520 PMID:19392992 PMID:19796209 PMID:27103662 |
RGD:5135018 RGD:5135019 RGD:5135020 |
NCBI chrNW_004624926:263,942...268,875
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
ISO |
|
RGD |
PMID:23221044 |
RGD:10043366 |
NCBI chrNW_004624742:25,177,340...25,356,911
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
susceptibility severity |
ISO |
DNA:SNP: :8473T>C (human) mRNA, protein:increased expression:lung: mRNA:increased expression:lung DNA:SNP: :rs689465 (human) |
RGD |
PMID:15316498 PMID:17573729 PMID:18097056 PMID:18489027 PMID:19342146 PMID:19862936 PMID:19878559 More...
|
RGD:5135514 RGD:5135515 RGD:5135522 RGD:5135526 RGD:5135534 RGD:5143923 RGD:5143931 |
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004624733:39,445,083...39,544,415
Ensembl chrNW_004624733:39,447,461...39,544,409
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
|
RGD |
PMID:18391481 |
RGD:2298885 |
NCBI chrNW_004624730:3,316,122...3,361,820
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
DNA:SNPs: :multiple |
RGD |
PMID:21803869 |
RGD:6482835 |
NCBI chrNW_004624745:22,921,180...23,158,250
Ensembl chrNW_004624745:22,921,120...23,157,876
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
OMIM:600807 |
MouseDO |
|
|
NCBI chrNW_004624764:9,192,067...9,218,617
Ensembl chrNW_004624764:9,191,556...9,248,252
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
susceptibility |
ISO |
associated with allergic rhinitis; DNA:SNP:exon:38G>A (human) ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD ClinVar |
PMID:9550363 PMID:9643286 PMID:12100044 PMID:21255142 |
RGD:5144226 |
NCBI chrNW_004624926:1,029,120...1,030,250
|
|
G |
Scgb3a2 |
secretoglobin family 3A member 2 |
susceptibility severity no_association |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:SNP:promoter:-112G>A (human) |
OMIM ClinVar RGD |
PMID:11813133 PMID:18089940 PMID:18201431 |
RGD:5144230 RGD:5144231 |
NCBI chrNW_004624774:7,305,272...7,308,514
Ensembl chrNW_004624774:7,305,239...7,308,592
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:21437035 PMID:21515793 |
RGD:5685685 RGD:5685696 |
NCBI chrNW_004624826:7,590,576...7,612,370
Ensembl chrNW_004624826:7,587,970...7,610,163
|
|
G |
Serpine1 |
serpin family E member 1 |
severity susceptibility no_association |
ISO |
protein:increased expression:plasma protein:increased activity, increased expression:plasma, lung DNA:polymorphism:promoter:rs1799768 (human) |
RGD |
PMID:18594148 PMID:19063817 PMID:19604112 PMID:19703828 |
RGD:4144831 RGD:4144832 RGD:4144833 RGD:4144836 |
NCBI chrNW_004624740:16,128,145...16,136,696
Ensembl chrNW_004624740:16,128,059...16,137,337
|
|
G |
Sftpb |
surfactant protein B |
|
ISO |
mRNA, protein:decreased expression:lung protein:decreased expression:lung, Clara cell protein:increased expression:lung |
RGD |
PMID:11472974 PMID:15816355 PMID:16629790 PMID:18926058 |
RGD:4143289 RGD:4143398 RGD:4143462 RGD:4143465 |
NCBI chrNW_004624749:17,486,483...17,495,822
Ensembl chrNW_004624749:17,486,518...17,493,846
|
|
G |
Sftpc |
surfactant protein C |
susceptibility |
ISO |
protein:increased expression:lung DNA:polymorphism: :p.A53T (human) mRNA, protein:decreased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:19910179 |
RGD:4143462 RGD:4143465 RGD:4144063 |
NCBI chrNW_004624758:17,742,439...17,744,664
Ensembl chrNW_004624758:17,742,415...17,744,655
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
mRNA, protein:increased expression:lung associated with Bronchitis;protein:increased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:16839409 PMID:18266831 PMID:18802356 |
RGD:4143462 RGD:4143465 RGD:4143508 RGD:4143516 RGD:4143517 |
NCBI chrNW_004624841:6,917,067...6,938,594
Ensembl chrNW_004624841:6,916,849...6,936,077
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
|
RGD |
PMID:12847242 |
RGD:5684966 |
NCBI chrNW_004624823:6,612,452...6,625,047
Ensembl chrNW_004624823:6,612,452...6,625,300
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
ISO |
|
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004624928:403,114...405,560
Ensembl chrNW_004624928:403,503...405,095
|
|
G |
Slc5a7 |
solute carrier family 5 member 7 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004624749:11,347,602...11,371,113
Ensembl chrNW_004624749:11,347,609...11,371,330
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
DNA:repeat:intron (human) |
RGD |
PMID:19806585 |
RGD:4889460 |
NCBI chrNW_004624786:2,673,285...2,711,432
Ensembl chrNW_004624786:2,672,552...2,710,914
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22867017 |
|
NCBI chrNW_004624745:20,032,003...20,037,958
Ensembl chrNW_004624745:20,032,011...20,037,958
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
|
RGD |
PMID:15743779 |
RGD:1581231 |
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18211752 PMID:28807506 |
RGD:2317290 |
NCBI chrNW_004624854:4,975,724...5,056,940
Ensembl chrNW_004624854:4,976,507...5,057,391
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
treatment |
ISO |
|
RGD |
PMID:16083555 PMID:19087723 |
RGD:7244151 RGD:7244153 |
NCBI chrNW_004624802:10,809,234...10,847,762
Ensembl chrNW_004624802:10,809,252...10,846,693
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11031342 |
RGD:5147836 |
NCBI chrNW_004624813:4,542,226...4,550,378
Ensembl chrNW_004624813:4,542,011...4,550,486
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
protein:increased expression:lung mRNA,protein:increased expression:lung mRNA:increased expression:lung |
RGD |
PMID:8240667 PMID:16409782 PMID:17392578 |
RGD:2304339 RGD:5147475 RGD:5147645 |
NCBI chrNW_004624749:28,243,667...28,455,012
Ensembl chrNW_004624749:28,243,640...28,455,086
|
|
G |
Tacr2 |
tachykinin receptor 2 |
|
ISO |
DNA:SNP:cds:p.G231E (human) |
RGD |
PMID:19880429 PMID:20175803 |
RGD:5147640 RGD:5147641 |
NCBI chrNW_004624754:3,658,128...3,670,432
Ensembl chrNW_004624754:3,656,319...3,670,432
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:12640628 |
RGD:5147845 |
NCBI chrNW_004624754:23,815,464...23,822,480
Ensembl chrNW_004624754:23,815,915...23,822,827
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:600807 |
CTD MouseDO |
PMID:15806396 |
|
NCBI chrNW_004624795:4,442,188...4,453,544
Ensembl chrNW_004624795:4,442,188...4,453,143
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
severity susceptibility |
ISO |
DNA:polymorphism:cds:924T>C(human) ClinVar Annotator: match by term: Asthma |
RGD ClinVar |
PMID:2955539 PMID:7929844 PMID:8428006 PMID:8613548 PMID:12000493 PMID:15805995 More...
|
RGD:11059534 RGD:11059535 |
NCBI chrNW_004624828:6,291,010...6,312,438
Ensembl chrNW_004624828:6,291,167...6,309,482
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
no_association onset |
ISO |
DNA:SNPs:promoter, exon:multiple (human) DNA:polymorphism: :-509C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) mRNA:increased expression:lung protein:increased expression:serum DNA:SNP:cds:915G>C (human) DNA:SNP: :-509C>T (human) |
RGD CTD |
PMID:16365456 PMID:17673695 PMID:18366906 PMID:18711258 PMID:19046298 PMID:19096005 PMID:19136038 PMID:19138248 PMID:19222424 PMID:19317336 PMID:19533439 PMID:19620629 PMID:20485865 More...
|
RGD:4143443 RGD:4145113 RGD:4145132 RGD:4145139 RGD:4145142 RGD:4145143 RGD:4145144 RGD:4145280 RGD:4145295 RGD:4145297 RGD:4145299 |
NCBI chrNW_004624907:162,567...175,696
Ensembl chrNW_004624907:161,569...176,605
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:20709825 |
RGD:5684984 |
NCBI chrNW_004624741:22,880,481...22,883,962
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004624750:1,776,197...1,817,279
Ensembl chrNW_004624750:1,775,744...1,817,385
|
|
G |
Tlr1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004624840:7,287,772...7,349,282
Ensembl chrNW_004624840:7,287,781...7,290,162
|
|
G |
Tlr10 |
toll like receptor 10 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004624840:7,269,628...7,273,316
|
|
G |
Tlr2 |
toll like receptor 2 |
susceptibility severity |
ISO |
DNA:SNP: :rs7656411 (human) DNA:SNP: :596T>C (human) DNA:SNP: :rs3804100 (human) DNA:polymorphism:cds:p.R753Q(human) DNA:SNP: :rs4696480 (human) |
RGD |
PMID:18202345 PMID:18787777 PMID:19096003 PMID:19148143 PMID:20685742 PMID:20815312 PMID:22402138 More...
|
RGD:2312679 RGD:4144171 RGD:4144228 RGD:4145334 RGD:4145343 RGD:4145352 RGD:7800732 |
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
|
|
G |
Tlr3 |
toll like receptor 3 |
no_association |
ISO |
DNA:snp:cds:p.L412F (human) Asthma, Virus-Induced; mRNA:increased expression:sputum (human) |
RGD |
PMID:14987294 PMID:17434873 PMID:17610940 PMID:21129050 PMID:21364926 |
RGD:5128500 RGD:5129226 RGD:5129475 RGD:5129478 RGD:5129493 |
NCBI chrNW_004624769:16,925,969...16,945,250
Ensembl chrNW_004624769:16,925,984...16,941,196
|
|
G |
Tlr4 |
toll like receptor 4 |
susceptibility no_association severity |
ISO |
DNA:Polymorphism:cds:p.D299G (human) DNA:SNPs: :rs10983755, rs1927914 (human) DNA:polymorphisms:cds:c.896A>G, 1196C>T (human) protein:decreased expression:leukocytes, mononuclear DNA:SNPs:: |
RGD |
PMID:15356557 PMID:16266379 PMID:19067129 PMID:19159017 PMID:19330007 PMID:20628601 PMID:20685742 More...
|
RGD:4144141 RGD:4144171 RGD:4144176 RGD:4144188 RGD:4144190 RGD:4144198 RGD:4144817 |
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
|
|
G |
Tlr6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP (human) DNA:SNP: :p.S249P (human) |
RGD |
PMID:15266299 PMID:18547625 |
RGD:4889528 RGD:4889538 |
NCBI chrNW_004624840:7,323,022...7,349,334
|
|
G |
Tnc |
tenascin C |
|
ISO |
DNA:SNP:exon:p.L1677I (human) protein:increased expression:bronchus basement membrane DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9310019 PMID:16115819 PMID:17125141 PMID:18305139 |
RGD:4889565 RGD:4889569 RGD:4889572 RGD:4889589 |
NCBI chrNW_004624760:20,044,900...20,137,260
Ensembl chrNW_004624760:20,044,826...20,137,616
|
|
G |
Tnf |
tumor necrosis factor |
no_association susceptibility |
ISO |
DNA:polymorphism:promoter: ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD OMIM ClinVar |
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12530118 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:22760475 PMID:22992668 More...
|
RGD:4143254 |
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:20484920 |
RGD:5131201 |
NCBI chrNW_004624860:3,111,244...3,123,041
Ensembl chrNW_004624860:3,111,630...3,122,711
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24453940 |
|
NCBI chrNW_004624733:40,964,020...41,006,381
|
|
G |
Trpa1 |
transient receptor potential cation channel subfamily A member 1 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism ovalbumin sensitization |
CTD RGD |
PMID:19458046 PMID:31969645 |
RGD:127285811 |
NCBI chrNW_004624744:18,997,273...19,042,838
Ensembl chrNW_004624744:18,997,462...19,042,227
|
|
G |
Ucn |
urocortin |
|
ISO |
associated with Hypersensitivity;mRNA, protein:increased expression:lung |
RGD |
PMID:16427607 |
RGD:1642781 |
NCBI chrNW_004624738:9,393,004...9,393,966
Ensembl chrNW_004624738:9,393,329...9,393,706
|
|
G |
Vdr |
vitamin D receptor |
no_association |
ISO |
DNA:SNPs: :multiple (human) DNA:SNPs (human) DNA:SNP (human) DNA:SNP: :rs7975232 (human) |
RGD |
PMID:15282200 PMID:19622139 PMID:20124605 PMID:21103062 |
RGD:4889854 RGD:4889866 RGD:4889867 RGD:4889868 |
NCBI chrNW_004624816:4,314,146...4,423,946
Ensembl chrNW_004624816:4,365,961...4,424,514
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
protein:increased expression:sputum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11907124 PMID:15201500 PMID:19178538 PMID:19263519 |
RGD:6892723 |
NCBI chrNW_004624754:15,929,414...15,943,637
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:16782752 PMID:21419198 |
RGD:5685381 RGD:5685620 |
NCBI chrNW_004624785:5,466,429...5,487,763
Ensembl chrNW_004624785:5,468,563...5,488,143
|
|
G |
Wdr36 |
WD repeat domain 36 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004624743:28,903,013...28,944,353
Ensembl chrNW_004624743:28,903,093...28,942,978
|
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
treatment |
ISO |
|
RGD |
PMID:30059697 |
RGD:39939057 |
NCBI chrNW_004624730:1,744,097...1,747,206
Ensembl chrNW_004624730:1,743,916...1,747,293
|
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
treatment |
ISO |
|
RGD |
PMID:23933317 |
RGD:40903070 |
NCBI chrNW_004624836:2,556,269...2,597,008
|
|
G |
Epx |
eosinophil peroxidase |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:11846868 |
RGD:13506893 |
NCBI chrNW_004624871:40,811...50,436
Ensembl chrNW_004624871:40,885...50,116
|
|
G |
Il25 |
interleukin 25 |
treatment |
ISO |
|
RGD |
PMID:17889290 |
RGD:40902975 |
NCBI chrNW_004624820:9,188,709...9,192,180
Ensembl chrNW_004624820:9,188,612...9,191,990
|
|
G |
LOC101697345 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663
|
|
G |
LOC101698463 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004624754:23,674,935...23,683,044
Ensembl chrNW_004624754:23,674,448...23,683,662
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chrNW_004624832:2,491,372...2,500,622
Ensembl chrNW_004624832:2,491,281...2,500,653
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20022477 PMID:20485159 |
RGD:4145619 |
NCBI chrNW_004624730:74,768,668...74,769,749
Ensembl chrNW_004624730:74,768,668...74,769,798
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chrNW_004624836:2,556,269...2,597,008
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15970796 PMID:16502481 PMID:20485159 |
RGD:5144000 |
NCBI chrNW_004624748:6,040,564...6,043,454
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chrNW_004624753:16,566,864...16,811,438
|
|
G |
Il4 |
interleukin 4 |
susceptibility |
ISO |
DNA:SNPs:promoter,5'UTR,intron:multiple |
RGD |
PMID:20921925 |
RGD:11528633 |
NCBI chrNW_004624733:39,412,800...39,420,079
|
|
G |
LOC101697345 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663
|
|
G |
LOC101703821 |
HLA class II histocompatibility antigen, DQ beta 1 chain |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chrNW_004624733:42,668,963...42,673,385
Ensembl chrNW_004624733:42,670,632...42,672,846
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004624864:804,950...813,419
Ensembl chrNW_004624864:807,253...813,381
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chrNW_004624920:542,479...575,760
Ensembl chrNW_004624920:540,750...575,855
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004624926:263,942...268,875
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15496426 |
|
NCBI chrNW_004624731:16,729,846...16,741,529
Ensembl chrNW_004624731:16,726,975...16,741,557
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004624832:6,948,638...6,952,664
Ensembl chrNW_004624832:6,948,572...6,952,719
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9487340 PMID:16502481 PMID:20485159 |
RGD:5143936 |
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chrNW_004624754:23,827,782...23,845,690
Ensembl chrNW_004624754:23,827,706...23,837,356
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004624795:4,442,188...4,453,544
Ensembl chrNW_004624795:4,442,188...4,453,143
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15898979 PMID:16502481 PMID:20485159 |
RGD:11059537 |
NCBI chrNW_004624828:6,291,010...6,312,438
Ensembl chrNW_004624828:6,291,167...6,309,482
|
|
|
G |
LOC101706353 |
HLA class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:SNPs,haplotype:introns: |
RGD |
PMID:22391069 |
RGD:13506908 |
NCBI chrNW_004624754:24,079,459...24,086,342
Ensembl chrNW_004624754:24,079,366...24,084,512
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma and nasal polyps |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004624795:4,442,188...4,453,544
Ensembl chrNW_004624795:4,442,188...4,453,143
|
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004624733:42,668,963...42,673,385
Ensembl chrNW_004624733:42,670,632...42,672,846
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chrNW_004624731:16,729,846...16,741,529
Ensembl chrNW_004624731:16,726,975...16,741,557
|
|
G |
Tbx21 |
T-box transcription factor 21 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar OMIM |
PMID:25741868 |
|
NCBI chrNW_004624795:4,442,188...4,453,544
Ensembl chrNW_004624795:4,442,188...4,453,143
|
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
exacerbates |
ISO |
associated with respiratory syncytial virus infectious disease;DNA:SNPs:protomer: (rs2233409) (human) |
RGD |
PMID:23487427 |
RGD:40902982 |
NCBI chrNW_004624838:1,384,337...1,387,602
Ensembl chrNW_004624838:1,384,204...1,390,205
|
|
|
G |
Ngf |
nerve growth factor |
treatment |
ISO |
|
RGD |
PMID:30681402 |
RGD:405100716 |
NCBI chrNW_004624772:11,009,765...11,070,050
Ensembl chrNW_004624772:11,010,845...11,070,017
|
|
|
G |
Epx |
eosinophil peroxidase |
treatment |
ISO |
|
RGD |
PMID:28751233 |
RGD:13506890 |
NCBI chrNW_004624871:40,811...50,436
Ensembl chrNW_004624871:40,885...50,116
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:10984370 |
RGD:4890423 |
NCBI chrNW_004624966:168,244...220,430
Ensembl chrNW_004624966:168,250...220,522
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (human) |
RGD |
PMID:19996575 |
RGD:4892021 |
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
|
RGD |
PMID:8630576 |
RGD:5147837 |
NCBI chrNW_004624749:28,243,667...28,455,012
Ensembl chrNW_004624749:28,243,640...28,455,086
|
|
|
G |
Acsl3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
|
RGD |
PMID:23526225 |
RGD:13831300 |
NCBI chrNW_004624823:2,323,939...2,387,213
Ensembl chrNW_004624823:2,324,345...2,381,420
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
|
RGD |
PMID:25344652 |
RGD:11354965 |
NCBI chrNW_004624912:350,201...432,410
Ensembl chrNW_004624912:350,157...426,712
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004624771:9,031,978...9,038,760
Ensembl chrNW_004624771:9,032,016...9,038,825
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:19935773 PMID:26344076 |
RGD:11251537 RGD:5037240 |
NCBI chrNW_004624802:11,662,851...11,664,444
Ensembl chrNW_004624802:11,662,753...11,665,418
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33075463 |
|
NCBI chrNW_004624754:24,138,086...24,140,900
|
|
G |
Cdh17 |
cadherin 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25918132 |
|
NCBI chrNW_004624763:1,543,341...1,621,970
Ensembl chrNW_004624763:1,543,048...1,621,978
|
|
G |
LOC101697345 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:SNP: : rs928976(human) |
RGD |
PMID:24709764 |
RGD:13506912 |
NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663
|
|
G |
LOC101698840 |
HLA class II histocompatibility antigen, DO alpha chain |
treatment |
ISO |
DNA:SNP: :rs3128935(human) |
RGD |
PMID:24709764 |
RGD:13506912 |
NCBI chrNW_004624754:23,725,903...23,729,446
Ensembl chrNW_004624754:23,725,986...23,727,765
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004624814:6,597,248...6,744,294
Ensembl chrNW_004624814:6,597,005...6,744,286
|
|
G |
Prkca |
protein kinase C alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004624870:1,589,775...2,023,160
Ensembl chrNW_004624870:1,596,102...2,023,172
|
|
G |
Prkd1 |
protein kinase D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004624820:2,408,562...2,726,199
Ensembl chrNW_004624820:2,408,360...2,726,606
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004624760:12,917,244...12,937,858
Ensembl chrNW_004624760:12,915,206...12,937,824
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
|
|
G |
Tenm3 |
teneurin transmembrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25918132 |
|
NCBI chrNW_004624769:12,831,899...13,579,957
Ensembl chrNW_004624769:13,104,585...13,579,136
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004624907:162,567...175,696
Ensembl chrNW_004624907:161,569...176,605
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
|
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
ClinVar Annotator: match by term: Platelet-activating factor acetylhydrolase deficiency |
ClinVar OMIM |
PMID:8675689 PMID:9412624 PMID:10194471 PMID:10733466 PMID:16787988 PMID:25741868 PMID:28406212 More...
|
|
NCBI chrNW_004624754:13,905,084...13,932,366
Ensembl chrNW_004624754:13,904,797...13,931,670
|
|
|
G |
Ifng |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20817868 |
RGD:4145651 |
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:9927362 |
RGD:4143184 |
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10934091 |
RGD:4890960 |
NCBI chrNW_004624733:39,544,487...39,558,943
Ensembl chrNW_004624733:39,556,797...39,559,119
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:10731862 |
RGD:5130994 |
NCBI chrNW_004624871:121,026...131,433
Ensembl chrNW_004624871:121,026...131,323
|
|